drug protocol number

E3401

drug sponsor

Novartis

drug study

N/A

drug trial site

King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)

drug status

Ongoing

drug phase